Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer.
Teresa KrausNatalia Shengelia-de LangeHolger EinspielerMarcus HackerAlexander HaugElisabeth Kretschmer-ChottGeorgios KaranikasPublished in: Endocrine connections (2024)
In this study, we examined the still commonly used routine diagnostic radioiodine whole-body scan in the first follow-up of patients with differentiated thyroid carcinoma. We questioned the necessity of the scan in patients with low stimulated thyroglobulin levels. Therefore, we combined retrospective data from the University Hospital in Vienna and in Tbilisi to analyze 370 patients. We were able to demostrate a highly significant relationship between low stimulated thyroglobulin levels (<0.5 ng/mL) and the outcome of the diagnostic scan at the first follow-up (χ = 14.7, P < 0.001).
Keyphrases
- computed tomography
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- electronic health record
- magnetic resonance imaging
- cross sectional
- dual energy
- clinical practice
- magnetic resonance
- fine needle aspiration
- patient reported outcomes
- machine learning
- big data
- patient reported